The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant.
Tang CK, Aoshi T, Jounai N, Ito J, Ohata K, Kobiyama K, Dessailly BH, Kuroda E, Akira S, Mizuguchi K, Coban C, Ishii KJ.
Tang CK, et al. Among authors: dessailly bh.
PLoS One. 2013;8(3):e60038. doi: 10.1371/journal.pone.0060038. Epub 2013 Mar 21.
PLoS One. 2013.
PMID: 23555875
Free PMC article.